Article

The future promise of advanced therapies in ophthalmology

Six years after the first approved gene therapy in ophthalmology, the field is seeing a flurry of activity in innovative cell and gene therapy (CGT) studies addressing high unmet needs. Here’s what could be in store for the future.

Louis Cicchini
Director, Scientific Affairs, Cell & Gene Therapy at Cencora

Fill out the form below to read more

Pardot Form

Related resources

Webinar

Breaking down barriers: Why early commercialization planning is key to a successful market entry strategy

Learn more

Story | Navigating complexity

A world without distributors

Learn more

Article

Build, preserve, manage, acquire: Finding the right model for the mature portfolio

Learn more

Connect with our cell and gene experts

Schedule some time with our cell and gene experts today. We look forward to hearing from you.